Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. HUMAN ALBUMIN GRIFOLS 20% [SIN01180P]

HUMAN ALBUMIN GRIFOLS 20% [SIN01180P]

Active ingredients: HUMAN ALBUMIN GRIFOLS 20%

Last updated 26 October 2025

Product Info

HUMAN ALBUMIN GRIFOLS 20%

[SIN01180P]

Product information

Active Ingredient and Strength

ALBUMIN (HUMAN SERUM) (VENOUS) - 0.2 G/ML

Dosage Form

INFUSION, SOLUTION

Manufacturer and Country

INSTITUTO GRIFOLS SA - SPAIN
GRIFOLS BIOLOGICALS LLC (OPTIONAL MANUFACTURER OF FRACTION V) - UNITED STATES

Registration Number

SIN01180P

Licence Holder

GRIFOLS ASIA PACIFIC PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

B05AA01

Therapeutic indications
Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.
The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

Posology
The concentration of the albumin preparation, dosage and the infusion-rate should be adjusted to the patient's individual requirements.
The dose required depends on the size of the patient, the severity of trauma or illness and on continuing fluid and protein losses. Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required.
If human albumin is to be administered, haemodynamic performance should be monitored regularly; this may include:

  • arterial blood pressure and pulse rate

  • central venous pressure

  • pulmonary artery wedge pressure

  • urine output

  • electrolyte

  • haematocrit/haemoglobin

This product is suitable for premature infants and dialysis patients.

Contraindications
Hypersensitivity to albumin preparations or to any of the excipients.